关于CAR-T疗法的有效性,安全性和成本效益
Emina Karahmet Sher1, Amina Džidić-Krivić1,2, Emma Pinjic3
1International Society of Engineering Science and Technology, Nottingham, UK.
British journal of clinical pharmacology
|February 19, 2026
概括
化学抗原受体 (CAR) T细胞疗法显示出超出血液癌症的前景,为固体瘤提供了新的希望. 克服毒性和成本等挑战是扩大这种免疫疗法的关键.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经彻底改变了血液恶性瘤的免疫疗法.
- 新兴研究表明,CAR T细胞治疗的潜力扩展到治疗各种固体瘤和其他癌症.
- 本文重点介绍了近期应用CAR T细胞治疗在各种癌症类型中的进展和挑战.
研究的目的:
- 审查CAR T细胞疗法治疗癌症的最新创新,包括多发性骨髓瘤,骨肉瘤,质母细胞瘤,黑色素瘤和儿科恶性瘤.
- 确定和讨论阻碍CAR T细胞疗法的有效性在固体瘤和耐火性癌症中的重大挑战.
- 探索增强CAR T细胞疗法的策略,例如向多个抗原,改善输送和组合疗法.
主要方法:
- 关于CAR T细胞治疗在瘤学中的应用的最新研究的文献综述.
- 分析挑战,包括抗原逃逸,点外瘤毒性,瘤透和成本效益.
- 探索潜在的解决方案,如多抗原向,增强输送和组合免疫疗法 (例如PD-1封锁).
主要成果:
- 卡尔T细胞疗法在治疗各种固体瘤和儿童癌症方面具有潜力,超出其在血液癌症中的既定作用.
- 确定的主要挑战包括抗原逃逸,'在点外瘤'毒性,瘤透不良以及成本问题.
- 提高疗效的策略包括向多种抗原,增强局部传递,并将CAR-T细胞与检查点抑制剂或其他免疫疗法结合起来.
结论:
- 卡尔T细胞疗法在扩大癌症治疗选择方面具有显著的前景,特别是在固体瘤中.
- 解决诸如毒性,瘤透和成本效益等挑战对于广泛的临床采用至关重要.
- 未来的研究应该专注于优化CAR T细胞疗法,并将其有效地整合到更广泛的癌症免疫疗法策略中,考虑伦理和健康技术评估框架.
相关概念视频
Electroconvulsive Therapy
1.4K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.4K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

